Previous Article | Next Article ![]()
Infection and Immunity, November 1999, p. 5723-5729, Vol. 67, No. 11
Molecular Genetics Laboratory, International
Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka-1000,
Bangladesh,1 and Department of
Microbiology and Molecular Genetics, Harvard Medical School,
Boston, Massachusetts 021152
Received 3 May 1999/Returned for modification 16 July 1999/Accepted 17 August 1999
The filamentous bacteriophage CTX Vibrio cholerae belonging
to the O1 or O139 serogroup is the etiologic agent of cholera, an acute
dehydrating diarrhea which is caused principally by the potent
enterotoxin cholera toxin (CT) produced by these organisms during
pathogenesis (30). The ctxAB operon, which
encodes the A and B subunits of CT, resides in the genome of CTX Besides toxigenic strains of V. cholerae which carry the CTX
prophage, Vibrio mimicus has also been implicated in
diarrheal disease, and some strains of V. mimicus have been
demonstrated to produce CT (7, 18, 31, 34). The mechanism
involved in the acquisition of ctxAB genes by V. mimicus, however, has not been clearly demonstrated. In the
present study we analyzed environmental strains of V. mimicus, isolated from surface waters in Bangladesh, for their
susceptibility and lysogenic conversion by CTX Bacterial strains, plasmids, and phages.
Strains of V. mimicus analyzed in the present study were isolated from surface
water samples collected in Dhaka between January and December 1997. The
strains were stored either in lyophilized form or in sealed deep
nutrient agar at room temperature until they were used for the present
study. Before use, the identities of the cultures were confirmed by
biochemical methods (8), and the presence or absence of
genes encoding CT, TCP, and ToxR, as well as the CTX
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Lysogenic Conversion of Environmental Vibrio
mimicus Strains by CTX
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
, which encodes cholera toxin
(CT) in toxigenic Vibrio cholerae, is known to propagate by infecting susceptible strains of V. cholerae by using the
toxin coregulated pilus (TCP) as its receptor and thereby causing the origination of new strains of toxigenic V. cholerae from
nontoxigenic progenitors. Besides V. cholerae, Vibrio
mimicus strains which are normally TCP negative have also been
shown to occasionally produce CT and cause diarrhea in humans. We
analyzed nontoxigenic V. mimicus strains isolated from
surface waters in Bangladesh for susceptibility and lysogenic
conversion by CTX
and studied the expression of CT in the lysogens
by using genetically marked derivatives of the phage. Of 27 V. mimicus strains analyzed, which were all negative for genes
encoding TCP but positive for the regulatory gene toxR, 2 strains (7.4%) were infected by CTX-Km
, derived from strain
SM44(P27459 ctx::km), and the phage genome integrated into the host chromosome, forming stable lysogens. The
lysogens spontaneously produced infectious phage particles in the
supernatant fluids of the culture, and high titers of the phage could
be achieved when the lysogens were induced with mitomycin C. This is
the first demonstration of lysogenic conversion of V. mimicus strains by CTX
. When a genetically marked derivative of the replicative form of the CTX
genome carrying a functional ctxAB operon, pMSF9.2, was introduced into nontoxigenic
V. mimicus strains, the plasmid integrated into the host
genome and the strains produced CT both in vitro and inside the
intestines of adult rabbits and caused mild-to-severe diarrhea in
rabbits. This suggested that in the natural habitat infection of
nontoxigenic V. mimicus strains by wild-type CTX
may
lead to the origination of toxigenic V. mimicus strains
which are capable of producing biologically active CT. The results of
this study also supported the existence of a TCP-independent mechanism
for infection by CTX
and showed that at least one species of
Vibrio other than V. cholerae may contribute to
the propagation of the phage.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
, a
filamentous bacteriophage which exists as a prophage in the chromosome
of toxigenic V. cholerae (39). We have previously
studied the induction of CTX prophage and demonstrated that the
propagation of CTX
is associated with the origination of new
toxigenic strains of V. cholerae from nontoxigenic
progenitors (12, 13). The receptor for CTX
for invading
V. cholerae cells is the toxin coregulated pilus (TCP), the
genes for which are located on a large DNA region referred to as the
TCP-ACF pathogenicity island, which includes the tcp and
acf gene clusters (20, 22). However, recent
studies involving molecular analysis of naturally occurring strains of
toxigenic V. cholerae have shown that although most
toxigenic strains carry the TCP pathogenicity island, a small proportion of toxigenic strains which are negative for genes encoding TCP also exist (15, 33).
and tested the
toxigenicity of the lysogens under laboratory conditions and inside the
intestines of adult rabbits, using genetically marked derivatives of
the phage. The study was designed to investigate whether CT-negative
V. mimicus strains are also infected and converted to
toxigenic strains by the phage and to evaluate the possible role of
V. mimicus in the propagation of CTX
in the natural habitat.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
attachment
sequence attRS, was tested with specific DNA probes or PCR
assays (9, 13). Details of the strains are presented in
Table 1. Relevant characteristics of reference bacterial strains and properties of phages and plasmids used
in this study are listed in Table 2.
TABLE 1.
Analysis of 27 V. mimicus strains isolated
from environmental surface waters in Bangladesh for rRNA gene
restriction patterns (ribotype), for presence of genes encoding CT,
TCP, and ToxR as well as the attRS sequence, and for
susceptibility of the strains to genetically marked derivatives
of CTX
TABLE 2.
Characteristics of V. cholerae reference
strains, plasmids, and phages used in the study
Recombinant DNA procedures.
For in vitro DNA manipulations,
pUC18, chromogenic substrate
(X-Gal-[5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside]),
and DNA restriction and modifying enzymes were purchased from Bethesda Research Laboratories (BRL) (Gaithersburg, Md.) and used in accordance with the manufacturer's suggestions. The strategy for the construction of a genetically marked derivative of the replicative form (RF) of the
CTX
genome carrying a functional ctxAB operon is shown in
Fig. 1. CTX-Km
, isolated from strain
SM44 (16, 39), was used to infect the classical biotype
strain O395. The RF of the phage genome pCTX-Km isolated from strain
O395(pCTX-Km) carried a kanamycin resistance (Kmr)
determinant in place of the ctxAB genes. Before reinstating the ctxAB genes into the RF DNA, a mutation was introduced
into the zot gene to stop phage morphogenesis
(39) by deleting a 0.4-kb MluI-BglI
fragment of the gene, and the resulting plasmid was designated pMSF9.
This was done by digesting pCTX-Km simultaneously with MluI
and BglI to excise a 0.4-kb portion of the DNA. The remaining 7.2-kb fragment was purified, the overhanging termini were
filled by the Klenow fragment of Escherichia coli DNA
polymerase I and ligated with T4 DNA ligase, and the DNA was
electroporated into strain O395. Kanamycin-resistant colonies were
selected and tested for the presence of the plasmid and for their
inability to produce CTX-Km
particles.
|
. Colonies which were
simultaneously resistant to kanamycin and ampicillin were screened for
the presence of a pUC18 derivative with a 3.2-kb BamHI
insert carrying the ctxAB genes and the gene encoding
Kmr, and this plasmid was designated pMSF9.1. The 3.2-kb
BamHI fragment of pMSF9.1 was isolated and ligated with the
5.9-kb BamHI fragment of pMSF9. The ligated DNA was used to
electroporate V. cholerae O395, and colonies were selected
for resistance to kanamycin. The ultimate plasmid construct designated
pMSF9.2 thus consisted of a functional ctxAB operon and a
Kmr cassette and most of the RF DNA of CTX
but was
unable to support the morphogenesis of infectious phage particles.
Preparation of phage.
CTX-Km
used in this study was
prepared from a culture of strain O395 carrying the RF of the phage
genome as described by us previously (13). Briefly, the
culture supernatant was sterilized by filtration through
0.22-µm-pore-size filters (Millipore Corporation, Bedford, Mass.). To
confirm that the filtrate did not contain any bacterial cells, aliquots
of the filtrate were streaked on Luria agar plates and incubated
overnight at 37°C. The filtrate was titrated for infectious phage
particles by incubating aliquots of the supernatants with strain RV508
for 30 min at 30°C and then selecting for colonies resistant to kanamycin.
Probes and PCR assays.
The gene probes used in this study to
detect the CTX
genome were a 0.5-kb EcoRI fragment of
pCVD27 (19) carrying part of the ctxA gene and an
840-bp region internal to the zot gene amplified by PCR from
the recombinant plasmid pBB241 as described previously (1,
11). The toxR gene probe was a 2.4-kb BamHI
fragment of pVM7 (25), which is a pBR322-derived plasmid
carrying the entire toxR gene. The 18-bp attRS
sequence was identified by using a synthetic oligonucleotide
corresponding to the attRS sequence (28). The
rRNA gene probe consisted of a 7.5-kb BamHI fragment of the
E. coli rRNA clone pKK3535 (2, 10). Colony blots
or Southern blots were prepared with nylon filters (Hybond; Amersham International plc., Ayelesbury, United Kingdom) and processed by
standard methods (24). The polynucleotide probes were
labeled by random priming (14) with a random-primer
DNA-labeling kit (BRL) and [
-32P]deoxycytidine
triphosphate (3,000 Ci/mmol; Amersham), and oligonucleotide probes were
labeled by 3' tailing with terminal deoxynucleotidyl transferase (BRL)
and [
-32P]dCTP (Amersham). Southern blots and colony
blots were hybridized with the labeled probes, and autoradiographs were
developed as described by us previously (9-12).
Infection of recipient strains.
The susceptibility of
V. mimicus strains to CTX
was assayed under laboratory
conditions by previously described methods (12, 13) with
CTX-Km
. Briefly, the recipient strains were grown in Luria-Bertani
(LB) medium (1% Bacto Tryptone, 0.5% Bacto Yeast Extract, 1% NaCl)
or in AKI medium (1.5% Bacto Peptone, 0.4% yeast extract, 0.5% NaCl,
0.3% NaHCO3, pH 7.4) at 30°C; the cells were precipitated by centrifugation and washed in fresh LB or AKI medium. The recipient cells and phage particles were mixed in the appropriate medium to a make an approximate final concentration of 106
bacterial cells and 106 phage particles per ml. The mixture
was incubated for 16 h at 30°C, and aliquots of the culture were
diluted and plated on Luria agar plates containing kanamycin (50 µg/ml) to select for kanamycin-resistant colonies and on plates
devoid of kanamycin to determine the total number of colonies. The
results were expressed as a percentage of the total colonies that
became resistant to kanamycin. In each round of assay, the V. cholerae O1 classical strains O395, RV508, and TCP2, a derivative
of strain O395 with tcpA deleted, and an El Tor biotype
strain, SA-406, were included as controls. To allow optimal expression
of the phage receptor TCP in the control strains, classical strains
were grown in LB medium whereas the El Tor strain was grown in AKI
medium. The V. mimicus strains were tested for susceptibility to the phage in both LB and AKI media separately.
Analysis of infected strains.
Representative colonies of
V. mimicus which were either infected by CTX-Km
or
electroporated with pMSF9.2 were grown in LB medium containing
kanamycin (50 µg/ml) and were analyzed for the presence of the phage
genome. Total DNA or plasmid DNA was extracted from overnight cultures
by standard methods (24) and purified with microcentrifuge
filter units (Ultrafree-Probind; Sigma). Integration of the phage
genome into the chromosome of the recipient cells was studied by
comparative Southern blot analysis of total DNA and plasmid
preparations from infected and native strains (see Fig. 2). Production
of extracellular phage particles by V. mimicus strains
infected with CTX-Km
was assayed by growing the strains in the
presence of mitomycin C (20 ng/ml) or without mitomycin C and titrating
the supernatant fluids of the cultures for the presence of phage
particles with strain RV508 as the recipient as described by us
previously (12, 13).
Assay for CT production.
The ability of V. mimicus strains carrying the integrated form of pMSF9.2 to produce
CT was determined by the GM1-ganglioside-dependent enzyme-linked immunosorbent assay (GM1-ELISA) and the
rabbit ileal loop assay as described previously (6, 9, 32).
To study the expression of CT in LB as well as in AKI medium, each
strain was tested separately with either of the media. For each round of CT assay, 5 ml of LB (pH 6.5) or AKI (pH 7.4) medium was inoculated with approximately 103 bacterial cells and grown for
16 h at 30°C with shaking. The culture was centrifuged at
4,000 × g for 5 min, and the supernatant was collected
and filtered through 0.22-µm-pore-size Millipore filters. Aliquots of
the undiluted supernatant, 10-fold and 100-fold dilutions of the
supernatant, and dilutions of purified CT (Sigma) were used for the
toxin assay. Briefly, 100 µl of the samples was added into each well
of microtiter plates precoated with GM1 and incubated at
room temperature for 90 min. After the plates were washed, with
phosphate-buffered saline containing 0.5% Tween-20, the
GM1-bound CT was reacted with rabbit anti-CT antibody
(Sigma). Antibody binding to CT was detected by reaction with
horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G
(whole-molecule) antibody (Sigma), and the substrates
o-phenyldiamine and hydrogen peroxide. Quantification of CT
production was done with a standard curve prepared for each batch of
assay. The amount of CT produced by each strain was the mean value of
five different assays with the same strain and culture conditions. The
classical strain 569B, El Tor strain P27457, and V. mimicus
strains lysogenized with CTX-Km
were used as positive and negative
control strains in each round of assay.
Ileal loop assay. Culture filtrates of the lysogens and the corresponding native strains, along with the control strains, were tested in ileal loops of adult New Zealand White rabbits obtained from the breeding facilities of the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B). A maximum of six ileal loops approximately 10 cm in length were made in each rabbit, which had previously been fasting for 48 h. Culture filtrates prepared for the ELISA test were also used for the ileal loop assay, and 1 ml of the filtrate was inoculated into each loop as described previously (6). Culture supernatant from each strain was tested in at least five rabbits. After 18 h, the rabbits were sacrificed and the loops were examined for fluid accumulation. The results were expressed as the volume of fluid accumulated in milliliters per centimeter of the loop.
Assay for diarrhea in rabbits. The diarrheal response of rabbits to V. mimicus strains carrying the integrated form of pMSF9.2 and to the corresponding native strains as well as the control strains were assayed in adult rabbits with the removable intestinal tie-adult rabbit diarrhea (RITARD) model (35). Adult New Zealand White rabbits weighing 1.5 to 2.7 kg were used to prepare the RITARD model. The rabbits were starved for the previous 24 h, and surgery was done under a local anesthetic. The cecum of each animal was ligated to prevent it from retaining fluid secreted by the small intestine, and a temporary removable tie of the small bowel was introduced at the time of challenge. Strains were grown in Casamino acid-yeast extract broth as described previously (35), and cells were precipitated by centrifugation and resuspended in 10 mM phosphate-buffered saline, pH 7.4, at a concentration of approximately 109 per ml. One ml of the suspension was injected into the lumen of the anterior jejunum. The removable tie in the intestine was removed after 2 h of inoculation. Each strain was inoculated in at least 5 different rabbits. The rabbits were observed for overt diarrhea and for death, and stools or rectal swabs were cultured on gelatin agar plates containing kanamycin whenever appropriate to monitor shedding of the challenge organisms. Observations were made at 6-h intervals during the following 5 days of inoculation, the number of rabbits developing moderate-to-severe diarrhea was arbitrarily scored, and the number of deaths was recorded. Rabbits that died with or without diarrhea were subjected to postmortem examinations to check for the presence of fluid in the intestine.
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
Species of the genus Vibrio have been regarded as a
group of organisms whose major habitats are aquatic ecosystems,
although several of the species are pathogenic in humans and produce
putative colonization factors, enterotoxins, hemolysins,
hemagglutinins, and possibly other virulence-associated factors.
V. cholerae, Vibrio parahaemolyticus, and
V. mimicus are known to cause diarrheal illness in humans
(8). It has been suggested that acquisition of
virulence-associated genes has allowed specific vibrios to adapt to the
human intestinal environment (13, 20). The most potent
enterotoxin, cholera toxin (CT) produced by toxigenic strains of
V. cholerae, is encoded by the CTX bacteriophage
(39), and propagation of the phage in its natural habitat is
associated with the origination of new toxigenic strains
(13). The factors associated with the propagation of the
phage and the evolutionary significance of its interaction with the
host bacteria have yet to be clearly elucidated. Preliminary studies by
us and others have shown that CTX
infects V. cholerae by
using the pilus colonization factor TCP as the receptor and lysogenizes
the susceptible bacteria (13, 39). This implies that CTX
should specifically infect V. cholerae strains which are
capable of expressing TCP. However, we have shown previously that a
V. cholerae non-O1 strain which was negative for TCP was
also infected by CTX
, although at a low efficiency (13).
This indicated that there may be an alternative TCP-independent
mechanism for CTX
infection and thus raised questions as to whether
CTX
is also able to infect and utilize strains belonging to other
species of the genus for its propagation. In the present study we
tested the susceptibility of environmental V. mimicus
strains to the phage and the expression of CT in these strains, since
V. mimicus has been reported to occasionally produce CT
(7, 34). In addition, we tested the ability of infected strains to produce extracellular phage particles in order to understand whether environmental strains of V. mimicus may also
contribute to the propagation of CTX
.
Distribution of virulence genes and attRS
sequence.
Naturally occurring toxigenic strains of V. cholerae carry the CTX
genome integrated in the chromosome at a
site specified by the attachment sequence attRS. In
addition, these strains normally possess genes for TCP and the
transcriptional regulator ToxR (17, 37). We screened the
V. mimicus strains in the present study for the presence of
these genes with either DNA probes or PCR assays. All V. mimicus strains studied were negative for the tcpA, tcpI, and acfB genes and presumably the entire
TCP pathogenicity island. To our knowledge, V. mimicus
strains have never been shown previously to carry genes encoding TCP,
although the species has close similarity with V. cholerae
(4, 8). However, all strains tested in the present study
carried the toxR gene and 19 of the 27 strains (70.3%)
carried the attRS sequence (Table 1). The toxR
gene has also been found to be widely distributed among nontoxigenic V. cholerae strains (13). This is probably
because ToxR is involved in the regulation of a number of genes in
addition to those encoding TCP and CT (5, 25-27) and may be
part of a common regulatory mechanism possessed by different species of
the genus. The high prevalence of the attRS sequence in
V. mimicus strains suggested that these strains were capable
of integrating the phage genome once it was inside the cell by whatever
means and thus that they can possibly act as a reservoir of the CTX
genome in the aquatic environment. This was further confirmed by the
observed integration of the phage derivative pMSF9.2 in the chromosomes
of V. mimicus strains which were electroporated with the
plasmid (Table 1).
Infection and analysis of recipient strains.
We used two
genetically marked derivatives of CTX
or its RF DNA, namely,
CTX-Km
, and pMSF9.2 (Table 2) to study the susceptibility of the
strains and their ability to express CT. The Kmr marker
present in the genome of the phage allowed us to conveniently detect
and analyze infected cells. Of 27 V. mimicus strains exposed to CTX-Km
, 2 strains (7.4%) were infected. These two V. mimicus strains were distinctly susceptible to the phage in
repeated assays, producing between 12 and 56 infected colonies per
107 live cells (susceptibility, between [1.2 × 10
6]% and [5.6 × 10
6]%). No
significant difference was noted in the phage susceptibility of these
two V. mimicus strains whether the strains were tested in LB
or AKI medium. The remaining 25 strains were completely resistant to
infection by the phage, and no kanamycin-resistant transductant was
detected in these strains when they were assayed under identical
conditions. The susceptibility of V. mimicus strains was
significantly low compared to that of the control V. cholerae classical biotype strains RV508 and O395 (mean, 89.1 and
45.2%, respectively) but was comparable to that of the nontoxigenic El Tor biotype strain SA-406 (mean susceptibility, [6.5 × 10
6]%), even when the strain was grown in AKI medium to
allow expression of TCP (the receptor for CTX
). This was probably
because the classical biotype strains expressed TCP more adequately
than the El Tor strain under in vitro conditions, and moreover, strain RV508 is a mutant that constitutively expresses TCP and other toxR-regulated genes. It was, however, interesting to note that 2 of 27 V. mimicus strains which did not carry genes for TCP were infected at an efficiency comparable to that of the TCP-positive El Tor
strain of V. cholerae O1. The present study thus showed for
the first time that besides V. cholerae some V. mimicus strains can also be infected by the phage and confirmed
our previous speculation (13) that in addition to the
TCP-mediated mechanism there may be a second mechanism for CTX
infection. However, the control strain, TCP2, which is a TCP-negative
derivative of the classical strain O395, was not infected by the phage
in repeated assays, although the parent strain was infected at high
frequency. Thus the TCP-independent infection by CTX
was strain
specific. However, it was not clear from this study what determined the
phage sensitivity of the two V. mimicus strains.
or electroporated with pMSF9.2, the phage genome integrated into the
chromosome of the host forming lysogens, as was evidenced by Southern
blot analysis of plasmid and chromosomal DNA preparations from
representative infected cells (Fig. 2).
Although plasmid preparations from the freshly infected cells showed
the presence of the phage genome, the lysogens spontaneously lost the
RF of the phage, as confirmed by subsequent plasmid preparations (data not shown). To analyze strains infected with CTX-Km
, which did not
carry the ctxA gene, chromosomal DNA was digested with
BglI to cleave within the zot gene
(1), and a zot probe was used to determine the
number of fragments produced. Since, in pMSF9.2, a deletion was
introduced in the zot gene, we used a different enzyme,
BglII, to digest chromosomal DNA derived from the
electroporated strains and used the ctxA probe. Since, there
is no BglII site within the ctxA gene, the number
of fragments produced represented the approximate number of copies of
the CTX
genome which integrated into the chromosome of the infected
cells. Thus, hybridization of BglI- or
BglII-digested genomic DNA from infected or electroporated strains with the zot or ctxA probe and
interpretation of the resulting restriction patterns as described
previously (9) confirmed that the phage genome integrated
into the chromosome of V. mimicus cells and two or three
copies of the phage genome were present in tandem repeats in different
host chromosomes (Fig. 2). The absence of a detectable level of the RF
DNA of the phage was evidenced by the absence of hybridization signals
in lanes containing plasmid preparations from the infected strains
(Fig. 2).
|
Expression of CT.
Unlike CTX-Km
(39), the newly
constructed derivative pMSF9.2 in the present study carried a
functional ctxAB operon, which allowed us to study the
expression of CT in the V. mimicus cells. The introduction
of a deletion mutation in the zot gene (Fig. 1) while
constructing pMSF9.2 was primarily a safety precaution to avoid the
creation of a live phage carrying both a wild-type ctxAB
operon and a gene encoding kanamycin resistance.
did not show a diarrheal response (Table 4),
but V. mimicus strains carrying integrated pMSF9.2, which
carried a functional ctxAB operon, produced diarrhea in
rabbits. This suggested that the diarrhea was in response to CT and not
due to other possible factors, such as zonula occludens toxin or
accessory cholera enterotoxin, which are also known to be encoded by
the CTX
genome (1, 39). Several previous studies have
shown that certain naturally occurring V. mimicus strains
produce enterotoxins identical to CT (7, 34). Hence, the
lysogenic conversion of V. mimicus strains by CTX
demonstrated in the present study under laboratory conditions may have
been occurring in the ecological habitat as well.
|
|
Regulation of CT expression in V. mimicus strains.
Expression of critical virulence genes in V. cholerae is
known to be coordinately regulated so that multiple genes respond in a
similar fashion to environmental conditions (5). Coordinate expression of virulence genes results from the activity of a cascading system of regulatory factors. ToxR, a 32-kDa transmembrane protein, is
the master regulator which is itself regulated by environmental signals. ToxR regulates not only the expression of ctxAB and
the TCP colonization factor, but also at least 17 distinct genes that constitute the ToxR regulon (5). The ToxR regulon is
controlled through another regulatory factor called ToxT, a 32-kDa
protein. ToxR controls the transcription of the toxT gene,
and the resulting increased expression of the ToxT protein leads to
activation of other genes in the ToxR regulon. In the present study,
the V. mimicus strains were negative for the entire TCP
pathogenicity island, which includes the toxT gene
(22), although these strains carried the toxR
gene. The expression of CT in these strains thus was independent of
toxT. It may be mentioned that V. cholerae has
ToxT-dependent and ToxT-independent branches of the ToxR regulon (3, 5). The ToxR protein binds to a tandemly repeated 7-bp DNA sequence found upstream of the ctxAB structural gene and
directly increases transcription of ctxAB, resulting in
higher levels of CT expression. In view of the absence of
toxT in the V. mimicus strains, it is likely that
ToxR directly regulated the expression of CT from the integrated form
of the CTX
genome in the V. mimicus lysogens. It may be
mentioned that CT can also be expressed from the RF of the CTX
genome independently of ToxR (23). However, in the present
study, the V. mimicus lysogens did not carry any detectable
level of the RF DNA, as evidenced by Southern blot hybridization of
plasmid preparations (Fig. 2).
Propagation of CTX
.
The V. mimicus lysogens of
CTX-Km
spontaneously produced infectious phage particles in the
supernatant fluids of culture (Table 5),
and high titers of the phage (mean, 4.2 × 105
particles/ml) could be obtained when induced with mitomycin C, as
determined by titration with strain RV508 as the recipient. The
demonstration of the presence of V. mimicus strains in the environment which were capable of harboring the CTX
genome and producing infectious phage particles indicated that some V. mimicus strains may have a role in supporting the replication and
propagation of CTX
in the environmental habitat. The discovery of
CTX
is beginning to provide an understanding of the role of
bacteriophages in the evolution of vibrios and the mutual benefit
imparted. Although the ctxAB genes do not have a direct role
in the morphogenesis of CTX
, the toxigenic property imparted by the
phage to its host provides greater evolutionary fitness to the
bacterium, since toxigenic strains are selectively enriched in the
intestinal environment. Moreover, acquisition of the diarrheagenic
property allows rapid spread of the bacteria and thus of the
bacteriophage. In the present study, although the number of rabbits
that developed fatal diarrhea in response to the V. mimicus
strains was less than that in response to the control El Tor strain,
the surviving rabbits shed the organisms in the diarrheal stools for 2 to 6 days. In previous studies the specificity of the phage towards
infecting V. cholerae was assumed to be a result of the
expression by V. cholerae of the pilus colonization factor,
TCP, which is also known to be the receptor for CTX
. In the present
study we demonstrated that CTX
can also infect selective strains of
V. mimicus and convert them to toxigenic strains capable of
producing diarrhea in the rabbit model. This study thus showed that at
least one Vibrio species other than V. cholerae
can contribute to the propagation of CTX
. Our efforts are at present
directed towards understanding the mechanism that allows
TCP-independent infection by CTX
and to further studying the
regulation of the ctxAB operon in V. mimicus.
|
| |
ACKNOWLEDGMENTS |
|---|
This research was funded by the United States Agency for International Development (USAID) under grant HRN-5986-A-00-6005-00 with the ICDDR,B. The ICDDR,B is supported by countries and agencies which share its concern for the health problems of developing countries.
We thank V. I. Mathan for helpful discussions and suggestions. We thank Manujendra N. Saha for helping with this study and Afjal Hossain for secretarial assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Molecular Genetics Laboratory, Laboratory Sciences Division, International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), GPO Box 128, Dhaka-1000, Bangladesh. Phone: 880 2 871751 to 880 2 871760. Fax: 880 2 872529 and 880 2 883116. E-mail: faruque{at}icddrb.org.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Baudry, B.,
A. Fasano,
J. Ketley, and J. B. Kaper.
1992.
Cloning of a gene (zot) encoding a new toxin produced by Vibrio cholerae.
Infect. Immun.
60:428-434 |
| 2. | Brosius, J., A. Ullrich, M. A. Raker, A. Gray, T. J. Dull, R. R. Gutell, and H. F. Noller. 1981. Construction and fine mapping of recombinant plasmids containing the rRNB ribosomal RNA operon of E. coli. Plasmid 6:112-118[Medline]. |
| 3. | Champion, G. A., M. N. Neely, M. A. Brennan, and V. J. DiRita. 1997. A branch in the ToxR regulatory cascade of Vibrio cholerae revealed by characterization of Tox T mutant strains. Mol. Microbiol. 23:323-331[Medline]. |
| 4. |
Davis, B. R.,
G. R. Fanning,
J. M. Madden,
A. G. Steigerwalt,
H. B. Bradford, Jr.,
H. L. Smith, Jr., and D. J. Brenner.
1981.
Characterization of biochemically atypical Vibrio cholerae strains and designation of a new pathogenic species, Vibrio mimicus.
J. Clin. Microbiol.
14:631-639 |
| 5. |
DiRita, V. J.,
C. Parsot,
G. Jander, and J. J. Mekalanos.
1991.
Regulatory cascade controls virulence in Vibrio cholerae.
Proc. Natl. Acad. Sci. USA
88:5403-5407 |
| 6. | De, S. N., and D. N. Chatterje. 1953. An experimental study of the mechanisms of action of Vibrio cholerae on the intestinal mucous membrane. J. Pathol. Bacteriol. 46:559-562. |
| 7. | Dotevall, H., G. Jonson-Stormberg, S. Sanyal, and J. Holmgren. 1985. Characterization of enterotoxin and soluble hemagglutinin from Vibrio mimicus; identity with V. cholerae O1 toxin and hemagglutinin. FEMS Microbiol. Lett. 27:17-22. |
| 8. | Farmer, J. J., III, F. W. H. Brenner, and T. M. Kelly. 1985. Vibrio, p. 281-301. In E. H. Lennete (ed.), Manual of clinical microbiology, 4th ed. American Society for Microbiology, Washington, D.C. |
| 9. | Faruque, S. M., K. M. Ahmed, A. R. M. A. Alim, F. Qadri, A. K. Siddique, and M. J. Albert. 1997. Emergence of a new clone of toxigenic Vibrio cholerae biotype El Tor displacing V. cholerae O139 Bengal in Bangladesh. J. Clin. Microbiol. 35:624-630[Abstract]. |
| 10. | Faruque, S. M., S. K. Roy, A. R. M. A. Alim, A. K. Siddique, and M. J. Albert. 1995. Molecular epidemiology of toxigenic V. cholerae in Bangladesh studied by numerical analysis of rRNA gene restriction patterns. J. Clin. Microbiol. 33:2833-2838[Abstract]. |
| 11. | Faruque, S. M., L. Comstock, J. B. Kaper, and M. J. Albert. 1994. Distribution of zonula occludens toxin (zot) gene among clinical isolates of Vibrio cholerae O1 from Bangladesh and Africa. J. Diarrhoeal Dis. Res. 12:222-224[Medline]. |
| 12. |
Faruque, S. M.,
Asadulghani,
A. R. M. A. Alim,
M. J. Albert,
K. M. N. Islam, and J. J. Mekalanos.
1998.
Induction of the lysogenic phage encoding cholera toxin in naturally occurring strains of toxigenic V. cholerae O1 and O139.
Infect. Immun.
66:3752-3757 |
| 13. |
Faruque, S. M.,
Asadulghani,
M. N. Saha,
A. R. M. A. Alim,
M. J. Albert,
K. M. N. Islam, and J. J. Mekalanos.
1998.
Analysis of clinical and environmental strains of nontoxigenic Vibrio cholerae for susceptibility to CTX : molecular basis for the origination of new strains with epidemic potential.
Infect. Immun.
66:5819-5825 |
| 14. | Feinberg, A., and B. Volgelstein. 1984. A technique for radio labelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137:266-267[Medline]. |
| 15. | Ghosh, C., R. K. Nandi, S. K. Dasgupta, G. B. Nair, R. H. Hall, and A. C. Ghose. 1997. A search for cholera toxin (CT), toxin coregulated pilus (TCP), the regulatory element ToxR and other virulence factors in non-O1/non-O139 Vibrio cholerae. Microb. Pathog. 22:199-208[Medline]. |
| 16. |
Goldberg, I., and J. J. Mekalanos.
1986.
Effect of a recA mutation on cholera toxin gene amplification and deletion events.
J. Bacteriol.
165:723-731 |
| 17. |
Herrington, D. A.,
R. H. Hall,
G. Losonsky,
J. J. Mekalanos,
R. K. Taylor, and M. M. Levine.
1988.
Toxin, toxin-coregulated pili and ToxR regulon are essential for Vibrio cholerae pathogenesis in humans.
J. Exp. Med.
168:1487-1492 |
| 18. |
Janda, J. M.,
C. Powers,
R. G. Bryant, and S. L. Abbott.
1988.
Current perspective on the epidemiology and pathogenesis of clinically significant Vibrio spp.
Clin. Microbiol. Rev.
1:245-267 |
| 19. | Kaper, J. B., J. G. Morris, Jr., and M. Nishibuchi. 1988. DNA probes for pathogenic Vibrio species, p. 65-77. In F. C. Tenover (ed.), DNA probes for infectious disease. CRC Press, Inc., Boca Raton, Fla. |
| 20. |
Karaolis, D. K.,
J. A. Johnson,
C. C. Bailey,
E. C. Boedeker,
J. B. Kaper, and P. R. Reeves.
1998.
A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains.
Proc. Natl. Acad. Sci. USA
95:3134-3139 |
| 21. | Keasler, S. P., and R. H. Hall. 1993. Detection and biotyping of Vibrio cholerae O1 with multiplex polymerase chain reaction. Lancet 341:1661[Medline]. |
| 22. | Kovach, M. E., M. D. Shaffer, and K. M. Peterson. 1996. A putative integrase gene defines the distal end of a large cluster of ToxR-regulated colonization genes in Vibrio cholerae. Microbiology 142:2165-2174[Abstract]. |
| 23. |
Lazar, S., and M. K. Waldor.
1998.
ToxR-independent expression of cholera toxin from the replicative form of CTX .
Infect. Immun.
66:394-397 |
| 24. | Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 25. |
Miller, V. L., and J. J. Mekalanos.
1984.
Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR.
Proc. Natl. Acad. Sci. USA
81:3471-3475 |
| 26. |
Miller, V. L., and J. J. Mekalanos.
1988.
A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR.
J. Bacteriol.
170:2575-2583 |
| 27. |
Parsot, C., and J. J. Mekalanos.
1991.
Expression of the Vibrio cholerae gene encoding aldehyde dehydrogenase is under control of ToxR, the cholera toxin transcriptional activator.
J. Bacteriol.
173:2842-2851 |
| 28. |
Pearson, G. D. N.,
A. Woods,
S. L. Chiang, and J. J. Mekalanos.
1993.
CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor.
Proc. Natl. Acad. Sci. USA
90:3750-3754 |
| 29. |
Popovic, T.,
C. Bopp,
O. Olsvic, and K. Wachsmuth.
1993.
Epidemiological application of a standardized ribotype scheme for Vibrio cholerae O1.
J. Clin. Microbiol.
31:2474-2482 |
| 30. | Rabbani, G. H., and W. B. Greenough. 1990. Cholera, p. 233-253. In E. Lebenthal, and M. Duffy (ed.), Textbook of secretory diarrhea. Raven Press Inc., New York, N.Y. |
| 31. | Ramamurthy, T., M. J. Albert, A. Huq, R. R. Colwell, Y. Takeda, T. Takeda, T. Shimada, B. K. Mandal, and G. B. Nair. 1994. Vibrio mimicus with multiple toxin types isolated from human and environmental sources. J. Med. Microbiol. 40:194-196[Abstract]. |
| 32. | Sack, D. A., S. Huda, P. K. B. Neogi, R. R. Daniel, and W. M. Spira. 1980. Microtiter ganglioside enzyme-linked immunosorbent assay for Vibrio and Escherichia coli heat labile enterotoxins and antitoxins. J. Clin. Microbiol. 1:35-40. |
| 33. | Said, B., H. R. Smith, S. M. Scotland, and B. Rowe. 1995. Detection and differentiation of the gene for toxin co-regulated pili (tcpA) in Vibrio cholerae non-O1 using the polymerase chain reaction. FEMS Microbiol. Lett. 125:205-210[Medline]. |
| 34. |
Spira, W. M., and P. J. Fedorka-Cray.
1984.
Purification of enterotoxins from Vibrio mimicus that appear to be identical to cholera toxin.
Infect. Immun.
45:679-684 |
| 35. |
Spira, W. M.,
R. B. Sack, and J. L. Froehlich.
1981.
Simple adult rabbit model for Vibrio cholerae and enterotoxigenic Escherichia coli diarrhea.
Infect. Immun.
32:739-747 |
| 36. | Taylor, R., C. Shaw, K. Peterson, P. Spears, and J. Mekalanos. 1988. Safe, live Vibrio cholerae vaccines? Vaccine 6:151-154[Medline]. |
| 37. |
Taylor, R. K.,
V. L. Miller,
D. B. Furlong, and J. J. Mekalanos.
1987.
Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin.
Proc. Natl. Acad. Sci. USA
84:2833-2837 |
| 38. |
Taylor, R. K.,
C. Manoil, and J. J. Mekalanos.
1989.
Broad-host-range vectors for delivery of TnphoA: use in genetic analysis of secreted virulence determinants of Vibrio cholerae.
J. Bacteriol.
171:1870-1878 |
| 39. | Waldor, M. K., and J. J. Mekalanos. 1996. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272:1910-1914[Abstract]. |
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|